Moors & Cabot’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.3K Hold
11,250
﹤0.01% 871
2025
Q1
$24.8K Buy
11,250
+500
+5% +$1.1K ﹤0.01% 859
2024
Q4
$16.4K Hold
10,750
﹤0.01% 877
2024
Q3
$21.4K Buy
+10,750
New +$21.4K ﹤0.01% 871